Product Information
CANDESARTAN CILEXETIL 32 MG TB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.5189 per EA under NDC 33342011710. Its NADAC has been published 486 times since Jun 14, 2017.
FDA first approved this application on Dec 5, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
32 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342011710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CANDESARTAN CILEXETILApproval Type
Generic (ANDA)
FDA Application
ANDA203813FDA Approved
12/5/2016
TE Code
AB
On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN CILEXETIL 32 MG TB has been published 486 times since Jun 14, 2017, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5189 per EA |
|---|---|
| All-time high | $2.7427 (Jul 12, 2017) |
| All-time low | $0.5107 (Aug 19, 2026) |
| 52-week high | $0.6049 |
| 52-week low | $0.5107 |
| Median price | $1.1070 |
| Average price | $1.2137 |
| Largest weekly change | -34.5% (Nov 20, 2024) |
| Weeks tracked | 486 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Candesartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CANDESARTAN CILEXETIL 32 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN CILEXETIL 32 MG TB, manufactured by Macleods Pharmaceuticals Limited, is $0.5189 per EA (NDC 33342011710), effective Sep 30, 2026.
How has the price of CANDESARTAN CILEXETIL 32 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has declined 80.5%. It has been tracked across 486 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for CANDESARTAN CILEXETIL 32 MG TB?
Since Jun 14, 2017, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has ranged from a low of $0.5107 (Aug 19, 2026) to a high of $2.7427 (Jul 12, 2017), with a median of $1.1070 per EA.
Are there cheaper alternatives to CANDESARTAN CILEXETIL 32 MG TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CANDESARTAN CILEXETIL 32 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN CILEXETIL 32 MG TB?
CANDESARTAN CILEXETIL 32 MG TB (NDC 33342011710) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.